510(k) · Cleared
ClearedDepilase Trio Lase Laser System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Depilase Group, Ltd. · GEX Powered Laser Surgical Instrument
Cleared on May 20, 2003 as substantially equivalent to K990718 (Laserscope, 2000) and 6 other predicates after a 90-day review. Its family tree reaches back 5 generations to 1996.
- Decided
- May 20, 2003
- Review
- 90 days
- Class
- Class II
- Product code
- GEX
- Recalls
- None
- Predicates
- 7
Its longest line of descent runs back 5 generations to K963094 (1996). 23 ancestors in all, the oldest K950019 (1995). No later device cites it as a predicate yet.
- Root · 5 generations backK963094 Cynosure Photogenica LP Dermatological Vascular Lesion LaserCynosure, Inc. · 1996
- 4 generations backK972767 Candela Gentlelase GL Dermatological Vascular Lesion LaserCandela Corp. · 1997 · Recalled
- 3 generations backK974381 Candela Gentlelase GL Dermatological LaserCandela Corp. · 1998
- 2 generations backK981351 Candela Gentlelase GL Dermatological LaserCandela Corp. · 1998
- 1 generation backK984601 Candela Gentlelase II Dermatological LaserCandela Corp. · 1999
- This deviceK030508 Depilase Trio Lase Laser SystemDepilase Group, Ltd. · 2003
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −5 | K963094 | Cynosure Photogenica LP Dermatological Vascular Lesion Laser | Cynosure, Inc. | 1996 | — |
| −4 | K972767 | Candela Gentlelase GL Dermatological Vascular Lesion Laser | Candela Corp. | 1997 | 1 |
| −3 | K974381 | Candela Gentlelase GL Dermatological Laser | Candela Corp. | 1998 | — |
| −2 | K981351 | Candela Gentlelase GL Dermatological Laser | Candela Corp. | 1998 | — |
| −1 | K984601 | Candela Gentlelase II Dermatological Laser | Candela Corp. | 1999 | — |
| 0 (this device) | K030508 | Depilase Trio Lase Laser System | Depilase Group, Ltd. | 2003 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 5 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 5 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GEX device
- #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (7)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K990718 | Orion Series Surgical Laser System (SL Seriesq-Switched ND:Yag Configuration)Summary page 2…Equivalence Depilase believes that its DEPILASE TRIO LASE Laser System system is substantially equivalent, regarding the Nd:YAG laser emission, to the Laserscope Lyra (K990718, K020021), and Altus Medical Aesthetic CoolGlide (K991798) Nd: YAG Lasers previously cleared for both the coagulation and hemosta… | 2000 |
| * | K020021 | Lyra Surgical Laser System and Accessiories (ND:Yag Configuration)Summary page 2…nce Depilase believes that its DEPILASE TRIO LASE Laser System system is substantially equivalent, regarding the Nd:YAG laser emission, to the Laserscope Lyra (K990718, K020021), and Altus Medical Aesthetic CoolGlide (K991798) Nd: YAG Lasers previously cleared for both the coagulation and hemostasis of va… | 2002 |
| * | K991798 | Acme Medical Aesthetic ND:Yag LaserSummary page 2…E Laser System system is substantially equivalent, regarding the Nd:YAG laser emission, to the Laserscope Lyra (K990718, K020021), and Altus Medical Aesthetic CoolGlide (K991798) Nd: YAG Lasers previously cleared for both the coagulation and hemostasis of vascular lesions, the removal and permanent reducti… | 2000 |
| * | K011939 | Fotona Dualis, Fotona Dualis Plus | 2001 |
| * | K994260 | Candela Gentlelase GL Dermatological LaserSummary page 2…lis KTP (KO1 1939), previously cleared for the coagulation and haemostasis of vascular lesions and regarding the Alexandrite laser emission, to the Candela GenteLASE GL (K994260), GenteLASE I1 (K984601) and the Cynosure Apogee TSK (K992757) Alexandrite lasers, all previously cleared for the removal of unwa… | 2000 |
| * | K984601 | Candela Gentlelase II Dermatological LaserSummary page 2…iously cleared for the coagulation and haemostasis of vascular lesions and regarding the Alexandrite laser emission, to the Candela GenteLASE GL (K994260), GenteLASE I1 (K984601) and the Cynosure Apogee TSK (K992757) Alexandrite lasers, all previously cleared for the removal of unwanted hair in Fitzpatrick… | 1999 |
| * | K992757 | Cynosure Apogee-TKS Dermatological LaserSummary page 2…haemostasis of vascular lesions and regarding the Alexandrite laser emission, to the Candela GenteLASE GL (K994260), GenteLASE I1 (K984601) and the Cynosure Apogee TSK (K992757) Alexandrite lasers, all previously cleared for the removal of unwanted hair in Fitzpatrick skin types I - IV They therefore hav… | 2000 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 7 years and passes through 3 companies; a new generation was cleared every 7 months on median.
- 1 of the 23 ancestors has a recall of any class.
- 5 other devices also cite its predicate K990718.
How does its category compare?
All GEX devicesGEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · GEX
83in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GEX
90in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GEX
3in 2024
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · GEX
2,720in 2025
MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 73 | 79 | 9 | 342 |
| 2008 | 107 | 86 | 2 | 232 |
| 2009 | 69 | 100 | 0 | 209 |
| 2010 | 50 | 96 | 4 | 1,711 |
| 2011 | 41 | 83 | 18 | 3,024 |
| 2012 | 45 | 118 | 5 | 2,000 |
| 2013 | 46 | 144 | 3 | 2,236 |
| 2014 | 61 | 147 | 6 | 2,036 |
| 2015 | 47 | 112 | 0 | 2,099 |
| 2016 | 51 | 114 | 1 | 2,585 |
| 2017 | 67 | 90 | 5 (1) | 2,977 |
| 2018 | 51 | 78 | 5 | 3,525 |
| 2019 | 41 | 88 | 6 | 2,709 |
| 2020 | 52 | 90 | 1 | 2,183 |
| 2021 | 53 | 123 | 0 | 3,465 |
| 2022 | 60 | 152 | 0 | 2,288 |
| 2023 | 52 | 87 | 6 | 2,337 |
| 2024 | 82 | 90 | 3 | 2,187 |
| 2025 | 83 | 90 | 0 | 2,720 |
| 2026 | 57 | 90 | 2 | — |
What is it indicated for?
The DEPILASE TRIO LASE Laser System is intended for the coagulation and haemostasis of vascular lesions (532 and 1064 nm), the removal and permanent reduction of unwanted hair in Fitzpatrick skin types I -VI, including suntanned skin types (755 and 1064 nm) and the dermatological applications for the non invasive treatment of facial wrinkles (1064 nm).
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K030508 · printed Nov 3, 2026
Cite this page
510(k) Report. “K030508: Depilase Trio Lase Laser System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K030508
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026